Oral Testosterone Ester Formulations and Methods of Treating Testosterone Deficiency Comprising Same
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 5 of these applications claim priority to application 12/758,770, filed Apr 12, 2010. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 8,778,916 | Oral Testosterone Ester Formulations and Methods of Treating Testosterone Deficiency Comprising Same In force · High confidence | Tolmar, Inc. | In force | High confidence | ||
| US 10,543,219 | Oral Testosterone Ester Formulations and Methods of Treating Testosterone Deficiency Comprising Same In force · High confidence | Tolmar, Inc. | In force | High confidence | ||
| US 10,617,696 | Oral Testosterone Ester Formulations and Methods of Treating Testosterone Deficiency Comprising Same In force · High confidence | Tolmar, Inc. | In force | High confidence | ||
| US 11,179,403 | Oral Testosterone Ester Formulations and Methods of Treating Testosterone Deficiency Comprising Same In force · High confidence | Tolmar, Inc. | In force | High confidence | ||
| US 11,426,416 | Oral Testosterone Ester Formulations and Methods of Treating Testosterone Deficiency Comprising Same In force · High confidence | Tolmar, Inc. | In force | High confidence | ||
| US 8,492,369 | Oral Testosterone Ester Formulations and Methods of Treating Testosterone Deficiency Comprising Same In force · High confidence | Tolmar, Inc. | In force | High confidence | ||
| US 12,778,967 | Methods of Treating Testosterone Deficiency In force · Medium confidence | Tolmar, Inc. | In force | Medium confidence | ||
| US 9,408,965 | Method and System for Handling and Transporting Syringes Lapsed Aug 9, 2024 on the fee record Ended Aug 9, 2024 · High confidence | Tolmar, Inc. | Lapsed Aug 9, 2024 on the fee record | Ended Aug 9, 2024 | High confidence | |
| Application 14/216,240 | Methods of Treating Testosterone Deficiency Abandoned Abandoned Jul 17, 2017 | Tolmar, Inc. | Abandoned | Abandoned Jul 17, 2017 | ||
| Application 14/290,540 | Oral Testosterone Ester Formulations and Methods of Treating Testosterone Deficiency Comprising Same Abandoned Abandoned Dec 23, 2016 | Tolmar, Inc. | Abandoned | Abandoned Dec 23, 2016 | ||
| 11 more patents in this group · Pro | ||||||
10 of 21 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 21, including 1 expired.
7 of these are in force and held by Tolmar, Inc..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.